FibroBiologics (FBLG) Amortizatization of Intangibles (2023)
FibroBiologics (FBLG) posted quarterly Amortizatization of Intangibles of $3000.0 for Q2 2023, down 96.15% on a QoQ basis from $78000.0 in Q1 2023.
FibroBiologics (FBLG) Amortizatization of Intangibles (2023) Analysis & Trends
FibroBiologics has reported Amortizatization of Intangibles for 1 years, with the latest figure at $3000.0 in Q2 2023.
- Amortizatization of Intangibles for Q2 2023 came in at $3000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $3000.0 (changed N/A YoY), and the FY2025 annual result was $625000.0, changed N/A from the prior year.
- Amortizatization of Intangibles retreated to $3000.0 in Q2 2023, from $78000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $78000.0 in Q1 2023 and troughed at $3000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - | 95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 78,000.00 |
| Mar 31, 2023 | 78,000.00 |